_id
6915fdb2bc934aba376b2819
Ticker
SPRC
Name
Scisparc Ltd
Exchange
NASDAQ
Address
Tower A, Tel Aviv, Israel, 6971916
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://scisparc.com
Description
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. It also sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv, Israel.
Last Close
1.4
Volume
87180
Current Price
1.07
Change
0.02
Last Updated
2026-01-07T12:16:23.270Z
Image
data:image/webp;base64,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
Ipo Date
2021-08-30T00:00:00.000Z
Market Cap
4834827
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.989
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
461000
Cost Of Revenue
290000
Gross Profit
171000
Operating Expenses
9322000
Operating Income
-9151000
Interest Expense
1058000
Pretax Income
-9412000
Net Income
-9328000
Eps
-17.919990163984817
Dividends Per Share
-
Shares Outstanding
3288998
Income Tax Expense
-
EBITDA
-7853000
Operating Margin
-1985.0325379609544
Total Other Income Expense Net
-261000
Cash
1566000
Short Term Investments
-
Receivables
1028999
Inventories
154000
Total Current Assets
2749000
Property Plant Equipment
41000
Total Assets
5139000
Payables
808000
Short Term Debt
2452000
Long Term Debt
-
Total Liabilities
5220000
Equity
-782000
Bs_currency_symbol
-
Depreciation
189000
Change In Working Capital
842000
Cash From Operations
-1861000
Capital Expenditures
0
Cash From Investing
-2100000
Cash From Financing
3967000
Net Change In Cash
6000
Cf_currency_symbol
-
PE
0.0042
PB
-0.7122423529411764
ROE
1192.8388746803068
ROA
-181.51391321268727
FCF
-1861000
Fcf Percent
-4.036876355748373
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
7
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
461000
Quarters > 0 > income Statement > cost Of Revenue
290000
Quarters > 0 > income Statement > gross Profit
171000
Quarters > 0 > income Statement > operating Expenses
9322000
Quarters > 0 > income Statement > operating Income
-9151000
Quarters > 0 > income Statement > interest Expense
1058000
Quarters > 0 > income Statement > pretax Income
-9412000
Quarters > 0 > income Statement > net Income
-9328000
Quarters > 0 > income Statement > eps
-17.919990163984817
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
520536
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7853000
Quarters > 0 > income Statement > operating Margin
-1985.0325379609544
Quarters > 0 > income Statement > total Other Income Expense Net
-261000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1566000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1028999
Quarters > 0 > balance Sheet > inventories
154000
Quarters > 0 > balance Sheet > total Current Assets
2749000
Quarters > 0 > balance Sheet > property Plant Equipment
41000
Quarters > 0 > balance Sheet > total Assets
5139000
Quarters > 0 > balance Sheet > payables
808000
Quarters > 0 > balance Sheet > short Term Debt
2452000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5220000
Quarters > 0 > balance Sheet > equity
-782000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-9328000
Quarters > 0 > cash Flow > depreciation
189000
Quarters > 0 > cash Flow > change In Working Capital
842000
Quarters > 0 > cash Flow > cash From Operations
-1861000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-2100000
Quarters > 0 > cash Flow > cash From Financing
3967000
Quarters > 0 > cash Flow > net Change In Cash
6000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-17.919990163984817
Quarters > 0 > ratios > PB
-0.7122423529411764
Quarters > 0 > ratios > ROE
1192.8388746803068
Quarters > 0 > ratios > ROA
-181.51391321268727
Quarters > 0 > ratios > FCF
-1861000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.036876355748373
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
466000
Quarters > 1 > income Statement > cost Of Revenue
434000
Quarters > 1 > income Statement > gross Profit
32000
Quarters > 1 > income Statement > operating Expenses
10875000
Quarters > 1 > income Statement > operating Income
-10843000
Quarters > 1 > income Statement > interest Expense
30000
Quarters > 1 > income Statement > pretax Income
-3812000
Quarters > 1 > income Statement > net Income
-2842000
Quarters > 1 > income Statement > eps
-1.4036612741115373
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2024705
Quarters > 1 > income Statement > income Tax Expense
-19000
Quarters > 1 > income Statement > EBITDA
-3666000
Quarters > 1 > income Statement > operating Margin
-2326.824034334764
Quarters > 1 > income Statement > total Other Income Expense Net
7031000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1540000
Quarters > 1 > balance Sheet > short Term Investments
517000
Quarters > 1 > balance Sheet > receivables
4963000
Quarters > 1 > balance Sheet > inventories
113000
Quarters > 1 > balance Sheet > total Current Assets
7503000
Quarters > 1 > balance Sheet > property Plant Equipment
59000
Quarters > 1 > balance Sheet > total Assets
10347000
Quarters > 1 > balance Sheet > payables
816000
Quarters > 1 > balance Sheet > short Term Debt
37000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1408000
Quarters > 1 > balance Sheet > equity
8154000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-4030000
Quarters > 1 > cash Flow > depreciation
263000
Quarters > 1 > cash Flow > change In Working Capital
-504000
Quarters > 1 > cash Flow > cash From Operations
-2907000
Quarters > 1 > cash Flow > capital Expenditures
1000
Quarters > 1 > cash Flow > cash From Investing
-1717000
Quarters > 1 > cash Flow > cash From Financing
5912000
Quarters > 1 > cash Flow > net Change In Cash
1288000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.4036612741115373
Quarters > 1 > ratios > PB
0.26568976575913666
Quarters > 1 > ratios > ROE
-34.854059357370616
Quarters > 1 > ratios > ROA
-27.466898617956897
Quarters > 1 > ratios > FCF
-2908000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-6.240343347639485
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
840000
Quarters > 2 > income Statement > cost Of Revenue
366000
Quarters > 2 > income Statement > gross Profit
474000
Quarters > 2 > income Statement > operating Expenses
-3053000
Quarters > 2 > income Statement > operating Income
3527000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3684000
Quarters > 2 > income Statement > net Income
-3442000
Quarters > 2 > income Statement > eps
-1.7000007408486668
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2024705
Quarters > 2 > income Statement > income Tax Expense
-5000
Quarters > 2 > income Statement > EBITDA
-3308000
Quarters > 2 > income Statement > operating Margin
419.88095238095235
Quarters > 2 > income Statement > total Other Income Expense Net
-7211000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
252000
Quarters > 2 > balance Sheet > short Term Investments
2308000
Quarters > 2 > balance Sheet > receivables
317000
Quarters > 2 > balance Sheet > inventories
415000
Quarters > 2 > balance Sheet > total Current Assets
3356000
Quarters > 2 > balance Sheet > property Plant Equipment
73000
Quarters > 2 > balance Sheet > total Assets
10482000
Quarters > 2 > balance Sheet > payables
1164000
Quarters > 2 > balance Sheet > short Term Debt
38000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1826000
Quarters > 2 > balance Sheet > equity
6920000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-3442000
Quarters > 2 > cash Flow > depreciation
219000
Quarters > 2 > cash Flow > change In Working Capital
640000
Quarters > 2 > cash Flow > cash From Operations
-2197000
Quarters > 2 > cash Flow > capital Expenditures
1000
Quarters > 2 > cash Flow > cash From Investing
92000
Quarters > 2 > cash Flow > cash From Financing
281000
Quarters > 2 > cash Flow > net Change In Cash
252000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-1.7000007408486668
Quarters > 2 > ratios > PB
0.3130685476878613
Quarters > 2 > ratios > ROE
-49.73988439306358
Quarters > 2 > ratios > ROA
-32.83724480061057
Quarters > 2 > ratios > FCF
-2198000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.6166666666666667
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
907000
Quarters > 3 > income Statement > cost Of Revenue
584000
Quarters > 3 > income Statement > gross Profit
323000
Quarters > 3 > income Statement > operating Expenses
-3525000
Quarters > 3 > income Statement > operating Income
3848000
Quarters > 3 > income Statement > interest Expense
178000
Quarters > 3 > income Statement > pretax Income
-2942000
Quarters > 3 > income Statement > net Income
-2242000
Quarters > 3 > income Statement > eps
-0.8144390378576112
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2752815
Quarters > 3 > income Statement > income Tax Expense
9000
Quarters > 3 > income Statement > EBITDA
-2582000
Quarters > 3 > income Statement > operating Margin
424.25578831312015
Quarters > 3 > income Statement > total Other Income Expense Net
-6790000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2076000
Quarters > 3 > balance Sheet > short Term Investments
3000000
Quarters > 3 > balance Sheet > receivables
287000
Quarters > 3 > balance Sheet > inventories
742000
Quarters > 3 > balance Sheet > total Current Assets
6445000
Quarters > 3 > balance Sheet > property Plant Equipment
108000
Quarters > 3 > balance Sheet > total Assets
11182000
Quarters > 3 > balance Sheet > payables
264000
Quarters > 3 > balance Sheet > short Term Debt
52000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1595000
Quarters > 3 > balance Sheet > equity
7614000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-2242000
Quarters > 3 > cash Flow > depreciation
271000
Quarters > 3 > cash Flow > change In Working Capital
241000
Quarters > 3 > cash Flow > cash From Operations
-2654000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-38000
Quarters > 3 > cash Flow > cash From Financing
2687000
Quarters > 3 > cash Flow > net Change In Cash
60000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.8144390378576112
Quarters > 3 > ratios > PB
0.3868547478329393
Quarters > 3 > ratios > ROE
-29.44575781455214
Quarters > 3 > ratios > ROA
-20.050080486496157
Quarters > 3 > ratios > FCF
-2654000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-2.926130099228225
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1306000
Annuals > 0 > income Statement > cost Of Revenue
800000
Annuals > 0 > income Statement > gross Profit
506000
Annuals > 0 > income Statement > operating Expenses
7822000
Annuals > 0 > income Statement > operating Income
-7316000
Annuals > 0 > income Statement > interest Expense
30000
Annuals > 0 > income Statement > pretax Income
-7486000
Annuals > 0 > income Statement > net Income
-6284000
Annuals > 0 > income Statement > eps
-1.078803468926546
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
5824972
Annuals > 0 > income Statement > income Tax Expense
-14000
Annuals > 0 > income Statement > EBITDA
-6974000
Annuals > 0 > income Statement > operating Margin
-560.1837672281777
Annuals > 0 > income Statement > total Other Income Expense Net
-170000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1540000
Annuals > 0 > balance Sheet > short Term Investments
517000
Annuals > 0 > balance Sheet > receivables
4963000
Annuals > 0 > balance Sheet > inventories
113000
Annuals > 0 > balance Sheet > total Current Assets
7503000
Annuals > 0 > balance Sheet > property Plant Equipment
59000
Annuals > 0 > balance Sheet > total Assets
10347000
Annuals > 0 > balance Sheet > payables
816000
Annuals > 0 > balance Sheet > short Term Debt
37000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1408000
Annuals > 0 > balance Sheet > equity
8154000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7472000
Annuals > 0 > cash Flow > depreciation
482000
Annuals > 0 > cash Flow > change In Working Capital
136000
Annuals > 0 > cash Flow > cash From Operations
-5104000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-1625000
Annuals > 0 > cash Flow > cash From Financing
6193000
Annuals > 0 > cash Flow > net Change In Cash
-536000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.078803468926546
Annuals > 0 > ratios > PB
1.050123723325975
Annuals > 0 > ratios > ROE
-77.06647044395389
Annuals > 0 > ratios > ROA
-60.732579491640095
Annuals > 0 > ratios > FCF
-5104000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.908116385911179
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2879000
Annuals > 1 > income Statement > cost Of Revenue
683000
Annuals > 1 > income Statement > gross Profit
2196000
Annuals > 1 > income Statement > operating Expenses
7969000
Annuals > 1 > income Statement > operating Income
-5773000
Annuals > 1 > income Statement > interest Expense
9000
Annuals > 1 > income Statement > pretax Income
-5861000
Annuals > 1 > income Statement > net Income
-5122000
Annuals > 1 > income Statement > eps
-2.51078431372549
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
2040000
Annuals > 1 > income Statement > income Tax Expense
22000
Annuals > 1 > income Statement > EBITDA
-5314000
Annuals > 1 > income Statement > operating Margin
-200.52101424105592
Annuals > 1 > income Statement > total Other Income Expense Net
-88000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2076000
Annuals > 1 > balance Sheet > short Term Investments
3000000
Annuals > 1 > balance Sheet > receivables
287000
Annuals > 1 > balance Sheet > inventories
742000
Annuals > 1 > balance Sheet > total Current Assets
6445000
Annuals > 1 > balance Sheet > property Plant Equipment
108000
Annuals > 1 > balance Sheet > total Assets
11182000
Annuals > 1 > balance Sheet > payables
264000
Annuals > 1 > balance Sheet > short Term Debt
52000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1595000
Annuals > 1 > balance Sheet > equity
7614000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5122000
Annuals > 1 > cash Flow > depreciation
538000
Annuals > 1 > cash Flow > change In Working Capital
-833000
Annuals > 1 > cash Flow > cash From Operations
-5887000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-1109000
Annuals > 1 > cash Flow > cash From Financing
5498000
Annuals > 1 > cash Flow > net Change In Cash
-1498000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.51078431372549
Annuals > 1 > ratios > PB
0.3938534278959811
Annuals > 1 > ratios > ROE
-67.27081691620698
Annuals > 1 > ratios > ROA
-45.80575925594706
Annuals > 1 > ratios > FCF
-5887000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.044807224730809
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1347000
Annuals > 2 > income Statement > cost Of Revenue
322000
Annuals > 2 > income Statement > gross Profit
1025000
Annuals > 2 > income Statement > operating Expenses
8405000
Annuals > 2 > income Statement > operating Income
-7380000
Annuals > 2 > income Statement > interest Expense
36000
Annuals > 2 > income Statement > pretax Income
-2578000
Annuals > 2 > income Statement > net Income
-2592000
Annuals > 2 > income Statement > eps
-2.9454545454545453
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
880000
Annuals > 2 > income Statement > income Tax Expense
14000
Annuals > 2 > income Statement > EBITDA
-2355000
Annuals > 2 > income Statement > operating Margin
-547.8841870824053
Annuals > 2 > income Statement > total Other Income Expense Net
4802000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3574000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
168000
Annuals > 2 > balance Sheet > inventories
668000
Annuals > 2 > balance Sheet > total Current Assets
4510000
Annuals > 2 > balance Sheet > property Plant Equipment
57000
Annuals > 2 > balance Sheet > total Assets
10605000
Annuals > 2 > balance Sheet > payables
298000
Annuals > 2 > balance Sheet > short Term Debt
27000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4156000
Annuals > 2 > balance Sheet > equity
6449000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2592000
Annuals > 2 > cash Flow > depreciation
187000
Annuals > 2 > cash Flow > change In Working Capital
-703000
Annuals > 2 > cash Flow > cash From Operations
-7917000
Annuals > 2 > cash Flow > capital Expenditures
4869000
Annuals > 2 > cash Flow > cash From Investing
-7084000
Annuals > 2 > cash Flow > cash From Financing
11700000
Annuals > 2 > cash Flow > net Change In Cash
-3301000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.9454545454545453
Annuals > 2 > ratios > PB
0.20058923864164988
Annuals > 2 > ratios > ROE
-40.19227787253838
Annuals > 2 > ratios > ROA
-24.441301272984443
Annuals > 2 > ratios > FCF
-12786000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-9.492204899777283
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1069000
Annuals > 3 > income Statement > cost Of Revenue
33000
Annuals > 3 > income Statement > gross Profit
1036000
Annuals > 3 > income Statement > operating Expenses
5768000
Annuals > 3 > income Statement > operating Income
-5768000
Annuals > 3 > income Statement > interest Expense
12000
Annuals > 3 > income Statement > pretax Income
-5789000
Annuals > 3 > income Statement > net Income
-5801000
Annuals > 3 > income Statement > eps
-7.343037974683544
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
790000
Annuals > 3 > income Statement > income Tax Expense
12000
Annuals > 3 > income Statement > EBITDA
-5744000
Annuals > 3 > income Statement > operating Margin
-539.5696913002806
Annuals > 3 > income Statement > total Other Income Expense Net
-21000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
6875000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2556000
Annuals > 3 > balance Sheet > inventories
45000
Annuals > 3 > balance Sheet > total Current Assets
9824000
Annuals > 3 > balance Sheet > property Plant Equipment
92000
Annuals > 3 > balance Sheet > total Assets
9916000
Annuals > 3 > balance Sheet > payables
441000
Annuals > 3 > balance Sheet > short Term Debt
486000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1775000
Annuals > 3 > balance Sheet > equity
8141000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-5789000
Annuals > 3 > cash Flow > depreciation
33000
Annuals > 3 > cash Flow > change In Working Capital
643000
Annuals > 3 > cash Flow > cash From Operations
-5061000
Annuals > 3 > cash Flow > capital Expenditures
35000
Annuals > 3 > cash Flow > cash From Investing
-70000
Annuals > 3 > cash Flow > cash From Financing
10060000
Annuals > 3 > cash Flow > net Change In Cash
4929000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-7.343037974683544
Annuals > 3 > ratios > PB
0.14264832330180566
Annuals > 3 > ratios > ROE
-71.25660238299963
Annuals > 3 > ratios > ROA
-58.50141185962081
Annuals > 3 > ratios > FCF
-5096000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.767072029934519
Annuals > 3 > health Score
33
Valuation > metrics > PE
0.0042
Valuation > metrics > PB
-0.7122423529411764
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
1192.8388746803068
Profitability > metrics > ROA
-339.3233903237541
Profitability > metrics > Net Margin
-20.234273318872017
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-8.649338374291116
Risk > final Score
-5
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8432515337423313
Liquidity > metrics > Quick Ratio
0.7960122699386503
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1386
Prev Risks > 1
98
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:37:02.901Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-04-24
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-6.2
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-6.2
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-11-04
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.7
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-1.7
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-03-31
Earnings History > 2 > report Date
2021-06-30
Earnings History > 2 > date
2021-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.7
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.7
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-12-31
Earnings History > 3 > report Date
2021-03-31
Earnings History > 3 > date
2020-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.7
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.7
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-09-30
Earnings History > 4 > report Date
2020-12-31
Earnings History > 4 > date
2020-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.505
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1.505
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-06-30
Earnings History > 5 > report Date
2020-09-30
Earnings History > 5 > date
2020-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.505
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.505
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-03-31
Earnings History > 6 > report Date
2020-06-30
Earnings History > 6 > date
2020-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-14
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-14
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-12-31
Earnings History > 7 > report Date
2020-03-31
Earnings History > 7 > date
2019-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-14
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-14
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-12-31
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-17.9126
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-17.9126
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-30
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-17.9126
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-17.9126
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-05-15
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-11-28
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-38.9456
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-38.9456
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-04-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-28.0003
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-28.0003
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-11-04
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.02
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-08-10
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.04
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-04
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-84.0022
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-84.0022
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-28.0004
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-28.0004
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-11-23
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-27.5865
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-27.5865
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-08-10
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-37.3461
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-37.3461
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-05-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-43.5466
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-43.5466
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-22
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-37.2073
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-37.2073
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-39.0744
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-39.0744
Earnings History > 23 > surprise Percent
-
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. It also sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv, Israel.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACritical Analysis: SciSparc (NASDAQ:SPRC) and ARS Pharmaceuticals (NASDAQ:SPRY) - Defense World
1/21/2026
Critical Analysis: SciSparc (NASDAQ:SPRC) and ARS Pharmaceuticals (NASDAQ:SPRY) Defense World
Read more →Fundamentals Check: Can SPRC weather a recession - Stock Surge & Risk Controlled Swing Trade Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Scisparc Ltd
1.
SBI Securities Co Ltd(0.0011%)
since
2025/06/30
2.
Bank of America Corp(0.0001%)
since
2025/06/30
3.
Rhumbline Advisers(0%)
since
2025/06/30
4.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
5.
Susquehanna International Group, LLP(0%)
since
2025/03/31
6.
JPMorgan Chase & Co(0%)
since
2025/03/31
7.
TWO SIGMA SECURITIES, LLC(0%)
since
2025/06/30
8.
UBS Group AG(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-6.2
EPS Estimate
0
EPS Difference
-6.2
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.